Investing.com -- Pfizer Inc plans to expand its obesity portfolio globally with a focus on oral medications following its Metsera acquisition, Chief Financial Officer Dave Denton said at the Jefferies ...

Saudi Arabia and the United States have signed an artificial intelligence strategic partnership during Saudi Crown Prince Mohammed bin Salman’s visit to Washington. “Signing the US-Saudi AI Strategic ...

Fueled by covid backlash, a libertarian author created the Brownstone Institute in 2021. In recent months, people with ties ...

Sudeep Pharma’s Rs 895-crore IPO is set to open on November 21, comprising a Rs 95-crore fresh issue and an Rs 800-crore OFS.

Saudi Crown Prince Mohammed bin Salman’s overtures to U.S. political and business leaders will continue Wednesday, but on ...

GSK has paid $50 million upfront to partner with LTZ Therapeutics on myeloid cell engagers, expanding its cancer pipeline to cover a modality that has attracted Eli Lilly, Novartis, Pfizer and Sanofi.

SC lawmakers advanced a bill that would require a disclaimer for COVID-19 vaccinations. Physicians have broadly encouraged ...

Drug candidates don't usually move among Big Pharma, but these five biotechs helped facilitate such hand-offs, scooping up ...

At the 2025 Society for Neuroscience meeting, scientists discussed the adverse side effects of GLP-1 agonists and new ...

COLUMBIA, S.C. — A South Carolina Senate Medical Affairs subcommittee heard more than an hour of conflicting testimony ...

Pfizer (PFE) stock is in focus as the company plans a $5B bond offering to fund its acquisition of obesity drug developer Metsera and other purposes. Read more here.

OLMA stock surged 197% after Roche’s SERD breakthrough, signaling investor conviction in the future of ER-positive breast ...